Mp-MRI in the Diagnosis of Liver Fibrosis After Liver Transplantation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-03-18

Study Completion Date

2022-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is an open label observation clinical trial, all participants are liver transplant patients. The investigators deem to make a better criteria for assessing liver fibrosis after liver transplantation. The point of the clinical trial is to evaluate the efficacy of multiparameter MRI in the diagnosis of liver fibrosis after liver transplantation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Exploring the Application Value of New Magnetic Resonance Imaging Technologies in Non-invasive Quantitative Assessment of Graft Function After Liver Transplantation

NCT06994429

Liver Transplantation MRI Graft Function

ENROLLING_BY_INVITATION

Multi-parametric Magnetic Resonance Imaging for the Precise Diagnosis and Quantitative Study of Liver Steatosis, Inflammation, and Fibrosis in Chronic Liver Disease.

NCT06463366

Liver Stiffness

RECRUITING

Liver Fat and Iron Quantification MRI

NCT03162302

Liver Diseases

COMPLETED

Explore New Magnetic Resonance Technology in Assessment of Renal Dysfunction

NCT06366529

Renal Insufficiency, Chronic

RECRUITING

Delta Radiomics for Liver Function Evaluation

NCT05296434

Chronic Liver Disease

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We collected patients aged 18 to 85 who had undergone liver transplantation. At the same time, all patients underwent liver biopsy or ultrasonic transient elastography after MRI. People who were allergic to gadolinium contrast agent, serious cardiopulmonary disease and contraindications to MRI were excluded.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Fibrosis After Liver Transplantation Multiparameter Magnetic Resonance Imaging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Gadopentetate Dimeglumine Injection

Patients with liver fibrosis after liver transplantation receive multi-parameter magnetic resonance scanning, percutaneous liver biopsy (or FibroScan).

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects aged 18 -85 years
* Patients after liver transplantation
* Patients who are going to undergo liver biopsy or ultrasonic transient elastography
* Patients voluntarily joined the study and signed informed consent

Exclusion Criteria

* Patients with tumor
* Patients who are allergic to gadolinium contrast agent
* Patients with contraindications to magnetic resonance imaging
* Patients with severe heart and lung diseases
* Patients who are not suitable for this study according to the researcher's judgment.

Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No